![]()
|
|
||||||||
J. Biol. Chem., Vol. 262, Issue 20, 9676-9680, 07, 1987
SS Simons Jr, JG Pumphrey, S Rudikoff and HJ Eisen
Recent results using proteases suggest that dexamethasone 21-mesylate (Dex-Mes) labeling of the rat hepatoma tissue culture (HTC) cell glucocorticoid receptor occurs at one or a few closely grouped cysteine residues (Simons, S.S., Jr. (1987) J. Biol. Chem. 262, 9669-9675). In this study, a more direct approach was used both to establish that only one cysteine is labeled by [3H]Dex-Mes and to identify the amino acid sequence containing this labeled cysteine. Various analytical procedures did not provide the purification of the extremely hydrophobic Staphylococcus aureus V8 protease digestion fragment that is required for unique amino acid sequencing data. Therefore, Edman degradation was performed on the limit protease digest mixtures which appeared to contain only one 3H-labeled peptide. These degradation experiments revealed the number of amino acid residues between the NH2 terminus of each peptide and the [3H]Dex-Mes-labeled cysteine. A comparison of these amino acid spacings with the published amino acid sequence of the HTC cell glucocorticoid receptor (Miesfeld, R., Rusconi, S., Godowski, P. J., Maler, B. A., Okret, S., Wikstom, A-C., Gustafsson, J-A., and Yamamoto, K. R. (1986) Cell 46, 389-399) indicated that the one cysteine labeled by [3H]Dex-Mes is Cys-656. Further analysis of the receptor sequence for the presence of the observed grouping of proteolytic cleavage sites, but without any preconditions as to which amino acid was labeled, gave Asp-122 and Cys- 656 as the only two possibilities. Potential labeling of Asp-122 could be eliminated on the basis of immunological and genetic evidence. We, therefore, conclude that the single Dex-Mes-labeled site of the HTC cell glucocorticoid receptor has been identified as Cys-656. Since several lines of evidence indicate that [3H]Dex-Mes labeling of the receptor occurs in the steroid binding site, Cys-656 is the first amino acid which can be directly associated with a particular property of the glucocorticoid receptor.
This article has been cited by other articles:
![]() |
S. H. Meijsing, C. Elbi, H. F. Luecke, G. L. Hager, and K. R. Yamamoto The Ligand Binding Domain Controls Glucocorticoid Receptor Dynamics Independent of Ligand Release Mol. Cell. Biol., April 1, 2007; 27(7): 2442 - 2451. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Giannoukos, D. Szapary, C. L. Smith, J. E. W. Meeker, and S. S. Simons Jr. New Antiprogestins with Partial Agonist Activity: Potential Selective Progesterone Receptor Modulators (SPRMs) and Probes for Receptor- and Coregulator-Induced Changes in Progesterone Receptor Induction Properties Mol. Endocrinol., February 1, 2001; 15(2): 255 - 270. [Abstract] [Full Text] |
||||
![]() |
C. Logie, M. Nichols, K. Myles, J. W. Funder, and A. F. Stewart Positive and Negative Discrimination of Estrogen Receptor Agonists and Antagonists Using Site-Specific DNA Recombinase Fusion Proteins Mol. Endocrinol., August 1, 1998; 12(8): 1120 - 1132. [Abstract] [Full Text] |
||||
![]() |
K. J. Modarress, J. Opoku, M. Xu, N. J. Sarlis, and S. S. Simons Jr. Steroid-induced Conformational Changes at Ends of the Hormone-binding Domain in the Rat Glucocorticoid Receptor Are Independent of Agonist Versus Antagonist Activity J. Biol. Chem., September 19, 1997; 272(38): 23986 - 23994. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. B. Pratt and D. O. Toft Steroid Receptor Interactions with Heat Shock Protein and Immunophilin Chaperones Endocr. Rev., June 1, 1997; 18(3): 306 - 360. [Abstract] [Full Text] |
||||
![]() |
D. Szapary, M. Xu, and S. S. Simons Jr. Induction Properties of a Transiently Transfected Glucocorticoid-responsive Gene Vary with Glucocorticoid Receptor Concentration J. Biol. Chem., November 29, 1996; 271(48): 30576 - 30582. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Xu, P. K. Chakraborti, M. J. Garabedian, K. R. Yamamoto, and S. S. Simons Jr. Modular Structure of Glucocorticoid Receptor Domains Is Not Equivalent to Functional Independence. STABILITY AND ACTIVITY OF THE STEROID BINDING DOMAIN ARE CONTROLLED BY SEQUENCES IN SEPARATE DOMAINS J. Biol. Chem., August 30, 1996; 271(35): 21430 - 21438. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. F. Stancato, A. M. Silverstein, C. Gitler, B. Groner, and W. B. Pratt J. Biol. Chem., April 12, 1996; 271(15): 8831 - 8836. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nakajima, J.-C. Hsieh, P. W. Jurutka, M. A. Galligan, C. A. Haussler, G. K. Whitfield, and M. R. Haussler Examination of the Potential Functional Role of Conserved Cysteine Residues in the Hormone Binding Domain of the Human 1,25-Dihydroxyvitamin D(3) Receptor J. Biol. Chem., March 1, 1996; 271(9): 5143 - 5149. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. Chrousos, S. D. Detera-Wadleigh, and M. Karl Syndromes of Glucocorticoid Resistance Ann Intern Med, December 1, 1993; 119(11): 1113 - 1124. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |